Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
奥拉帕尼治疗BRCA突变和同源重组缺陷的铂敏感复发性卵巢癌:II期LIGHT研究最终总生存期分析
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35707
Liu, Ying L; Mathews, Cara A; Simpkins, Fiona; Cadoo, Karen A; Provencher, Diane; McCormick, Colleen C; ElNaggar, Adam C; Altman, Alon D; Gilbert, Lucy; Black, Destin; Kabil, Nashwa; Taylor, Rosie N; Barnicle, Alan; Munley, Jiefen Y; Aghajanian, Carol